We are live on ! Find out more
CERE

Cerevel Therapeutics Holdings, Inc. Common Stock
CERE

Delisted

CERE was delisted on the 31st of July, 2024.

Back to rankings

210 hedge funds and large institutions have $6.67B invested in Cerevel Therapeutics Holdings, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 45 funds opening new positions, 82 increasing their positions, 49 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more repeat investments, than reductions

Existing positions increased: 82 | Existing positions reduced: 49

55% more first-time investments, than exits

New positions opened: 45 | Existing positions closed: 29

27% more call options, than puts

Call options by funds: $60M | Put options by funds: $47.1M

8% more funds holding

Funds holding: 195 → 210 (+15)

0% more capital invested

Capital invested by funds: $6.64B → $6.67B (+$31.3M)

9% less funds holding in top 10

Funds holding in top 10: 11 → 10 (-1)

Holders
210
Holders Change
+15
Holders Change %
+7.69%
% of All Funds
3.03%
Holding in Top 10
10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-9.09%
% of All Funds
0.14%
New
45
Increased
82
Reduced
49
Closed
29
Calls
$60M
Puts
$47.1M
Net Calls
+$12.9M
Net Calls Change
+$10.5M

Top Buyers

Rank Fund Capital Flow
1
SFM
Soros Fund Management
New York
+$81.5M
2
UOC
UBS O'Connor
Illinois
+$63.2M
3
Citigroup
Citigroup
New York
+$58.1M
4
PCM
Pentwater Capital Management
Florida
+$47M
5
Marshall Wace
Marshall Wace
United Kingdom
+$38.2M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$332M
2
RSCM
Rock Springs Capital Management
Maryland
-$89.3M
3
Morgan Stanley
Morgan Stanley
New York
-$41.9M
4
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$36.3M
5
Westfield Capital Management
Westfield Capital Management
Massachusetts
-$33.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
TMAM
51
Tokio Marine Asset Management
Japan
$16.4M +$16.3M +387,800 New
HI
52
HBK Investments
Texas
$15.2M +$15.1M +359,718 New
State of Wisconsin Investment Board
53
State of Wisconsin Investment Board
Wisconsin
$14.5M +$12M +285,521 +490%
T. Rowe Price Associates
54
T. Rowe Price Associates
Maryland
$14.2M -$16.2M -385,698 -53%
GLA
55
Great Lakes Advisors
Illinois
$14.1M +$14M +333,321 New
UBS Group
56
UBS Group
Switzerland
$12.9M +$3.67M +87,421 +40%
AAA
57
Affinity Asset Advisors
New York
$12.7M -$18.9M -450,000 -60%
Bank of New York Mellon
58
Bank of New York Mellon
New York
$12.2M -$894K -21,274 -7%
FTCM
59
First Trust Capital Management
Illinois
$11.7M +$11.6M +276,229 New
Capital International Investors
60
Capital International Investors
California
$10.7M -$25.6M -610,291 -71%
RAM
61
Readystate Asset Management
Illinois
$10.3M +$10.2M +243,900 New
Hudson Bay Capital Management
62
Hudson Bay Capital Management
Connecticut
$9.43M +$5.7M +135,674 +155%
Rafferty Asset Management
63
Rafferty Asset Management
New York
$9.4M +$3.4M +80,837 +57%
Bank of America
64
Bank of America
North Carolina
$9.34M +$6.24M +148,612 +206%
N
65
Nuveen
North Carolina
$8.8M -$100K -2,386 -1%
SAM
66
Stansberry Asset Management
Texas
$8.02M +$7.97M +189,788 New
Qube Research & Technologies (QRT)
67
Qube Research & Technologies (QRT)
United Kingdom
$7.42M +$7.37M +175,530 New
PMAM
68
Picton Mahoney Asset Management
Ontario, Canada
$6.34M -$3.15M -75,000 -33%
NYLIM
69
New York Life Investment Management
New York
$6.16M +$6.13M +145,842 New
Allianz Asset Management
70
Allianz Asset Management
Germany
$6.1M – – –
Swiss National Bank
71
Swiss National Bank
Switzerland
$6.05M +$147K +3,500 +3%
CG
72
Carmignac Gestion
France
$6M +$4.11M +97,834 +221%
Canada Pension Plan Investment Board
73
Canada Pension Plan Investment Board
Ontario, Canada
$5.71M -$2.39M -56,985 -30%
Verition Fund Management
74
Verition Fund Management
Connecticut
$5.61M +$2.22M +52,823 +66%
VI
75
Versor Investments
New York
$5.47M +$876K +20,860 +19%
1 2
3
4 5

CERE Hedge Fund Activity: Q1 2024 in Review

210 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) for Q1 2024, worth a combined $6.67B — up 0.47% from $6.64B a quarter earlier.

Buyers outnumbered sellers: 45 funds opened new CERE positions and 29 closed out — a net gain of 16 holders — while 82 added to existing stakes and 49 trimmed.

The largest buyer was Soros Fund Management, opening a new position worth an estimated $81.5M. The largest seller was Fidelity Investments, cutting an estimated $332M.

  • 210 institutional investors held Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) as of Q1 2024, up from 195 in Q4 2023.
  • Funds reported $6.67B of Cerevel Therapeutics Holdings, Inc. Common Stock stock for Q1 2024, up 0.47% quarter-over-quarter.
  • 45 funds opened new Cerevel Therapeutics Holdings, Inc. Common Stock positions in Q1 2024 and 29 closed out, a net change of +16 holders.
  • The largest Cerevel Therapeutics Holdings, Inc. Common Stock buyer in Q1 2024 was Soros Fund Management, an estimated $81.5M added.
  • The largest Cerevel Therapeutics Holdings, Inc. Common Stock seller in Q1 2024 was Fidelity Investments, an estimated $332M sold.

Based on aggregated 13F filings for Q1 2024.